Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Oct 24,2017
Study Suggests E-Cigarettes Are Just as Harmful as Cigarette Smoking
E-cigarette use around the world is booming, especially amongst young people. In 2016 the US Surgeon General identified a 900 percent increase in e-cigarette use in high school students from 2011 to 2015. While e-cigarette vapor certainly doesn't contain the same kinds of carcinogenic compounds as regular cigarette smoke, there is a growing body ofRead more
More
Study Suggests E-Cigarettes Are Just as Harmful as Cigarette Smoking
Oct 24,2017
Novel RNA Switch Dramatically Boosts Expression
Researchers at Northwestern University say they have developed a novel technique that dramatically boosts gene expression. According to Julius Lucks, Ph.D., an associate professor of chemical and biological engineering in the university's McCormick School of Engineering, if scientists could precisely regulate gene expression, they could turn off the genes responsible for illness and disease andRead more
More
Novel RNA Switch Dramatically Boosts Expression
Oct 23,2017
Breast Cancer Recycles Toxic Waste to Restock Nitrogen for Growth
Scientists may have hit upon a new therapeutic strategy against breast cancer with the finding that breast tumor cells recycle the ammonia that is generated as a byproduct of normal cell metabolism and use the toxic waste as a source of nitrogen to fuel their growth. The studies, by researchers at Harvard Medical School (HMS) andRead more
More
Oct 23,2017
Skin Cancer Starts When Tanning Goes Wrong in Mutated Stem Cells
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknown — until now. The origin of melanoma, oneRead more
More
Skin Cancer Starts When Tanning Goes Wrong in Mutated Stem Cells
Oct 20,2017
Wasabi Pain Pathway in Worms May Lead to New Pain Meds for Humans
Scientists at Northwestern University say they have discovered how scalding heat and tissue injury activate an ancient pain receptor in simple organisms. Their study ("Activation of Planarian TRPA1 by Reactive Oxygen Species Reveals a Conserved Mechanism for Nociception”), published in Nature Neuroscience, may lead to new strategies for analgesic drug design for treating people, noteRead more
More
Oct 20,2017
Novel Parkinson's Therapy Suggested by New Research Findings
An international scientific team reports that they have shed light on the molecular mechanism underlying Parkinson's protein LRRK2. The group, which found a direct link between the protein's dimerization and mutations that lead to Parkinson's disease, believes their work could eventually lead to new therapies for this devastating disease. They report the results of theirRead more
More
Novel Parkinson's Therapy Suggested by New Research Findings
Oct 20,2017
GLP Toxicology Studies
To assess toxicity, Medicilon offers a wide range of GLP and non-GLP toxicology services. GLP and non-GLP Toxicology studies are required to determine the adverse effects of drug candidates and the effect of dosage on toxicity. Preclinical CRO / Toxicology Studies Include: Late-Stage Discovery Studies Pharmacokinetics Study (PK) Maximum Tolerated Dose Studies (MTD) Dose RangeRead more
More
GLP Toxicology Studies
Oct 19,2017
Intermittent Fasting Boosts Fat Burning and Improves Metabolic Function
Studies in mice by a Canadian research team have shown how intermittent fasting (IF) without any calorie restriction results in animals shedding fat and losing body weight, leads to improved glucose homeostasis, and also protects against metabolic dysfunction. The Canadian research team, led by Kyoung-Han Kim, Ph.D., at the Hospital for Sick Children in Toronto,Read more
More
Intermittent Fasting Boosts Fat Burning and Improves Metabolic Function
Oct 19,2017
Epigenetics Linked to Resistance for Anti-Cancer Drug
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors with genetic mutations that make them resistant to these anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, or the cancers develop resistance during treatment. ResearchersRead more
More
Oct 18,2017
Microbial Drug Resistant Mutations Found via Novel Genome Screen
A scientific team from the Chalmers University of Technology and the University of Gothenburg, Sweden, report the discovery of a number of previously unknown antibiotic-resistant genes. The researchers found the genes by searching large volumes of bacterial DNA collected from humans and various environments from all over the world. Their study ("Identification of 76 NovelRead more
More
Microbial Drug Resistant Mutations Found via Novel Genome Screen
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->